BSE filing, NSE: LINKPH. Summary written from the filing by ALFA Finder's alert engine.
Link Pharma Chem Ltd: key numbers
- Share price
- ₹25.60
- Market cap
- ₹11.37 Cr
- Revenue (annual)
- ₹27.43 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- -1748.6×Sector 34.5×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Link Pharma Chem Ltd
All →Link Pharma Chem Board Meeting Date
Link Pharma Chem's board meets on 3 November 2026 to approve unaudited half-year results. The trading window stays closed until results are declared.
Link Pharma Chem Legal & Regulatory
Link Pharma Chem Ltd received a GST order reducing the total demand and penalty for FY 2021-22. The company plans to appeal the decision.
- Value
- ₹0.18 Cr
Link Pharma Chem Management Change
Link Pharma Chem Limited has announced the re-appointment of Rishikesh Thakur and Satish G Thakur as Executive Directors for a term of 36 months each.
Link Pharma Chem Annual General Meeting
Link Pharma Chem Ltd. held its 41st Annual General Meeting on August 20, 2026, where shareholders transacted various ordinary and special business items.
Link Pharma Chem Q1 FY27 Results: Net Profit ₹0.3 Cr, Down 25.0% YoY
Link Pharma Chem Ltd reported revenue from operations of ₹8.8 Cr (+12.8% YoY) and net profit of ₹0.3 Cr (-25.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · -25.0% YoY
Link Pharma Chem Other Announcement
Link Pharma Chem Ltd notified the exchange regarding the dispatch of letters to shareholders containing the web link for the Annual Report 2025-2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.